Donald Bobo - Edwards Lifesciences President

President

Mr. Donald E. Bobo Jr. is Corporationrationrate Vice President Strategy and Corporationrationrate Development of Edwards Lifesciences Corporationration Mr. Bobo was Corporationrationrate Vice President since 2007 and is responsible for Edwards corporate strategy and corporate development functions. In addition, Mr. Bobo has executive responsibility for the Companys disease awareness and heart failure initiatives, as well as the healthcare solutions and commercial services team since 2015.
Age 62
Tenure 9 years
Phone949 250 2500
Webhttps://www.edwards.com
Bobo has more than 30 years of experience in the medical products and healthcare industry and has served in various operating roles at Edwards, including most recently, the leadership of the Company’s transcatheter mitral and tricuspid therapies organization, the global heart valve therapy business and global valve manufacturing operations. Prior to joining Edwards in 1995, Mr. Bobo held a variety of roles with increasing levels of responsibility with American Hospital Supply and Baxter Healthcare Corporationrationrationration. He has served on the Board and Executive Committee of the California Life Sciences Association since 2015 and served as its Chairman of the Board from May 2017 to May 2018.

Edwards Lifesciences Management Efficiency

The company has Return on Asset (ROA) of 0.1225 % which means that for every $100 of assets, it generated a profit of $0.1225. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.2234 %, which means that it produced $0.2234 on every 100 dollars invested by current stockholders. Edwards Lifesciences' management efficiency ratios could be used to measure how well Edwards Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.1 in 2024. Return On Capital Employed is likely to drop to 0.14 in 2024. At this time, Edwards Lifesciences' Intangibles To Total Assets are fairly stable compared to the past year. Fixed Asset Turnover is likely to climb to 4.91 in 2024, whereas Debt To Assets are likely to drop 0.07 in 2024.
The company reports 694.9 M of total liabilities with total debt to equity ratio (D/E) of 0.11, which may suggest the company is not taking enough advantage from financial leverage. Edwards Lifesciences Corp has a current ratio of 3.75, indicating that it is in good position to pay out its debt commitments in time. Debt can assist Edwards Lifesciences until it has trouble settling it off, either with new capital or with free cash flow. So, Edwards Lifesciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Edwards Lifesciences Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Edwards to invest in growth at high rates of return. When we think about Edwards Lifesciences' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 14 records

PRESIDENT Age

Stuart HockridgeAlign Technology
52
Yuval ShakedAlign Technology
44
Markus SebastianAlign Technology
N/A
Sian RobertsAlign Technology
N/A
Jennifer ErfurthAlign Technology
45
Zelko RelicAlign Technology
59
Sreelakshmi KolliAlign Technology
49
Christopher PucoAlign Technology
56
Lynn PendergrassAlign Technology
55
Brad JergensonAlign Technology
N/A
Simon BeardAlign Technology
57
Jennifer OlsonAlign Technology
40
Julie TayAlign Technology
51
Raj PudipeddiAlign Technology
45
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 15700 people. Edwards Lifesciences Corp (EW) is traded on New York Stock Exchange in USA. It is located in One Edwards Way, Irvine, CA, United States, 92614 and employs 19,800 people. Edwards Lifesciences is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Edwards Lifesciences Corp Leadership Team

Elected by the shareholders, the Edwards Lifesciences' board of directors comprises two types of representatives: Edwards Lifesciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Edwards. The board's role is to monitor Edwards Lifesciences' management team and ensure that shareholders' interests are well served. Edwards Lifesciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Edwards Lifesciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Paul LaViolette, Independent Director
John Cardis, Independent Director
Wesley Schack, Presiding Independent Director
Larry Wood, Corporate Vice President - Transcatheter Aortic Valve Replacement
Leslie Heisz, Independent Director
Catherine Szyman, Corporate Vice President - Critical Care
Arnold Pinkston, Corporate Counsel
Barbara McNeil, Independent Director
Steven Loranger, Independent Director
Scott Ullem, Chief Financial Officer, Corporate Vice President
Patrick Verguet, Corporate VP of EMEA, Canada and Latin America
Kieran Gallahue, Independent Director
Nicholas Valeriani, Independent Director
Heisz Stone, Independent Director
Mark Wilterding, Vice Relations
MD FACC, Corporate Officer
Angela Fuente, Director Engineering
Martha Marsh, Lead Independent Director
Daveen Chopra, Corporate Vice President - Surgical Structural Heart
Huimin Wang, Corporate Vice President - Japan, Asia and Pacific
JeanLuc Lemercier, Corporate Vice President - EMEA (Europe, Middle East and Africa)
Christine McCauley, Corporate Resources
William Link, Independent Director
Gary Sorsher, Senior Compliance
Ramona Sequeira, Independent Director
Bernard Zovighian, Corporate Vice President -Surgical Heart Valve Therapy
David Erickson, Vice President - Investor Relations
Daniel Lippis, Greater Japan
Donald Bobo, Corporate Vice President - Strategy and Corporate Development
Todd Brinton, Co Officer
Dirksen Lehman, Corporate Affairs
Finn Haley, Vice Development
Michael Mussallem, Chairman of the Board, Chief Executive Officer

Edwards Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Edwards Lifesciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Edwards Lifesciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Edwards Lifesciences' short interest history, or implied volatility extrapolated from Edwards Lifesciences options trading.

Pair Trading with Edwards Lifesciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.

Moving against Edwards Stock

  0.66SINT SINTX TechnologiesPairCorr
  0.59BBLG Bone Biologics Corp Financial Report 20th of May 2024 PairCorr
  0.52HCAT Health Catalyst Financial Report 14th of May 2024 PairCorr
  0.51RSLS ReShape LifesciencesPairCorr
  0.45CMAX CareMax TrendingPairCorr
The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.
The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Tools for Edwards Stock

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamental Analysis
View fundamental data based on most recent published financial statements
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings